Zobrazeno 1 - 10 of 215 pro vyhledávání: '"JA López Guerrero"'
1
Report from the OECI Oncology days 2014
Autor: F Paparo, F Lemare, Darius Razavi, P De Paoli, PA Cadariu, F. De Lorenzo, Johannes Haybaeck, GA Rollandi, Gunnar Folprecht, Giovanni Bussolati, Peter Riegman, JA López Guerrero, Giorgio Stanta, T Ciuleanu, Marco A. Pierotti, Claudio Lombardo, József Lövey, S Zupo, R Buiga, W.H. van Harten, Mauro Truini, A Bagg, M Dono, Karl-Friedrich Becker, Gerald Hoefler, Mahasti Saghatchian, N. Goedbloed, G Weiner
Publikováno v: ecancermedicalscience, 8
Ecancermedicalscience, 8(496):496. Cancer Intellilgence
ecancermedicalscience
ecancermedicalscience, 8:A496. Cancer Intellilgence
The 2014 OECI Oncology Days was held at the 'Prof. Dr. Ion Chiricuta' Oncology Institute in Cluj, Romania, from 12 to 13 June. The focus of this year's gathering was on developments in personalised medicine and other treatment advances which have mad
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::affe003e3d03b3cc6c101cfbb8fce7b6
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195982
Zobrazit plný text záznamu
2
[Non-invasive diagnosis of prostate cancer: serum and urine markers]
Autor: Rubio-Briones J, Irene Casanova-Salas, Fernández-Serra A, Casanova Ramón-Borja J, Ramírez Backhaus M, Collado Sierra A, Domínguez-Escrig J, Gómez-Ferrer A, Ja, López-Guerrero
Publikováno v: Europe PubMed Central
The great number of biomarkers basic research is presenting in different clinical scenarios of prostate cancer demands the scientific community rigor in their molecular and clinical development for the selection of those which could supply diagnostic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::01612b8b32effa2e9af668a2b2cae450
http://europepmc.org/abstract/med/23793762
Zobrazit plný text záznamu
3
[Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)]
Autor: Ja, López Guerrero, Bolufer P, Barragán E, Miguel Sanz, Palau J, Sempere A, De la Rubia J, Bonanad S, Md, Torregrosa
Publikováno v: Publons
The sensitivity and specificity of a reverse transcription PCR method (RT-PCR) to detect cytokeratin K19 (CK19) expression was evaluated with the purpose of assessing its capability to detect the presence of breast cancer tumour cells in peripheral b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::32eaff4356b7e0fe6f31fbc0de5d9b42
https://publons.com/publon/18483791/
Zobrazit plný text záznamu
5
[Update on the diagnosis of PCa in urine. The current role of urine markers]
Autor: Fernandez-Serra A, Irene Casanova-Salas, Rubio L, Calatrava A, García-Flores M, García-Casado Z, Ja, López-Guerrero, Rubio-Briones J
Publikováno v: Europe PubMed Central
Prostate cancer (PCa) is still a main health issue, in fact it is responsible for 10% of cancer deaths across Europe. The morphology of the prostate gland makes urine an ideal sample, non invasive, for determination both diagnostic and prognostic bio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::51ec44413439c7b57c8f4107cc1f2b98
http://europepmc.org/abstract/med/25948797
Zobrazit plný text záznamu
6
Akademický článek
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
Autor: Mondaza-Hernandez JL; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain., Hindi N; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Fernandez-Serra A; Molecular Biology Department, Fundación Instituto Valenciano de Oncologia, Valencia, Spain., Ramos R; Pathology Department, University Hospital Son Espases, Mallorca, Spain., Gonzalez-Cámpora R; Pathology Department, Hospital Quironsalud, Cordoba, Cordoba, Spain., Gómez-Mateo MC; Department of Pathology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Lavernia J; Medical Oncology Department, Fundación Instituto Valenciano de Oncologia, Valencia, Spain., Lopez-Pousa A; Medical Oncology Department, Sant Pau Hospital, Barcelona, Spain., Laínez N; Department of Medical Oncology, Complejo Hospitalario de Navarra Pamplona, Spain., Martinez-Garcia J; Medical Oncology Department, University Hospital Virgen de la Arrixaca, Murcia, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Vaz-Salgado MÁ; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, CIBERONC, Madrid, Spain., Garcia-Plaza G; Department of Surgery, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain., Marin-Borrero I; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Carrillo-Garcia J; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain., Martin-Ruiz M; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain., Romero P; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain., Gutierrez A; Hematology Department, Hospital Son Espases/IdISBa, Palma de Mallorca, Spain., López-Guerrero JA; Molecular Biology Department, Fundación Instituto Valenciano de Oncologia, Valencia, Spain., Moura DS; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Martin-Broto J; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Reyes Católicos 2, Madrid 28040, Spain.; University Hospital General de Villalba, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain.
Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Nov 04; Vol. 16, pp. 17588359241293951. Date of Electronic Publication: 2024 Nov 04 (Print Publication: 2024).
Zobrazit plný text záznamu
7
Akademický článek
The Impact of Tube Type, Centrifugation Conditions, and Hemolysis on Plasma Circulating MicroRNAs.
Autor: Pastor-Navarro B; Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Peptide and Protein Laboratory, Department of Medicinal Chemistry, Unidad Mixta Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain.; Medicine and Health Sciences Faculty, Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain., Ramírez-Calvo M; Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain., Gil-Aldea I; Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain., Cortell-Granero I; Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain., López-Guerrero JA; Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Peptide and Protein Laboratory, Department of Medicinal Chemistry, Unidad Mixta Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain.; Medicine and Health Sciences Faculty, Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain.
Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Oct 24; Vol. 14 (21). Date of Electronic Publication: 2024 Oct 24.
Zobrazit plný text záznamu
8
Akademický článek
Human Coronavirus 229E Uses Clathrin-Mediated Endocytosis as a Route of Entry in Huh-7 Cells.
Autor: Andreu S; Departamento de Biología Molecular, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas), 28049 Madrid, Spain., Ripa I; Departamento de Biología Molecular, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas), 28049 Madrid, Spain., López-Guerrero JA; Departamento de Biología Molecular, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas), 28049 Madrid, Spain., Bello-Morales R; Departamento de Biología Molecular, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas), 28049 Madrid, Spain.
Publikováno v: Biomolecules [Biomolecules] 2024 Sep 29; Vol. 14 (10). Date of Electronic Publication: 2024 Sep 29.
Zobrazit plný text záznamu
9
Akademický článek
Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes.
Autor: Andreu Z; Polymer Therapeutics Laboratory and Screening Platform, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. zandreu@fivo.org.; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. zandreu@fivo.org.; Computational Biomedicine Laboratory, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. zandreu@fivo.org.; Laboratory of Molecular Biology, Foundation of the Valencian Institute of Oncology, Valencia, 46009, Spain. zandreu@fivo.org., Hidalgo MR; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Computational Biomedicine Laboratory, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Department of Mathematics, School of Mathematics, University of Valencia, Valencia, 46010, Spain., Masiá E; Polymer Therapeutics Laboratory and Screening Platform, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; CIBERONC, Carlos III Health Institute (IISCIII), Madrid, Spain., Romera-Giner S; Computational Biomedicine Laboratory, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Malmierca-Merlo P; Computational Biomedicine Laboratory, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., López-Guerrero JA; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Laboratory of Molecular Biology, Foundation of the Valencian Institute of Oncology, Valencia, 46009, Spain.; Department of Pathology, Medical School, Catholic University of Valencia 'San Vicente Mártir', Valencia, 46001, Spain., García-García F; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. fgarcia@cipf.es.; Computational Biomedicine Laboratory, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. fgarcia@cipf.es., Vicent MJ; Polymer Therapeutics Laboratory and Screening Platform, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. mjvicent@cipf.es.; IVO-CIPF Joint Cancer Research Unit, Príncipe Felipe Research Center (CIPF), Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain. mjvicent@cipf.es.; CIBERONC, Carlos III Health Institute (IISCIII), Madrid, Spain. mjvicent@cipf.es.
Publikováno v: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Aug 22; Vol. 81 (1), pp. 363. Date of Electronic Publication: 2024 Aug 22.
Zobrazit plný text záznamu
10
Akademický článek
Comprehensive Screening of Genetic Variants in the Coding Region of F8 in Severe Hemophilia A Reveals a Relationship with Disease Severity in a Colombian Cohort.
Autor: Sarmiento Doncel S; Integral Solutions SD SAS, Integral Solutions Research, Bogota 110121, Colombia.; Life Sciences and Health Research Group, Graduates School, CES University, Medellin 050021, Colombia.; Doctoral School, Catholic University of Valencia San Vicente Mártir (UCV), 46002 Valencia, Spain., Peláez RG; Life Sciences and Health Research Group, Graduates School, CES University, Medellin 050021, Colombia., Lapunzina P; Instituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; CIBERER, Centro de Investigación en Red de Enfermedades Raras, Instituto de Salud Carlos III, 28029 Madrid, Spain.; ITHACA, European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability, 75019 Paris, France., Corrales-Medina FF; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Miami-Miller School of Medicine, Miami, FL 33136, USA.; University of Miami-Hemophilia Treatment Center, Miami, FL 33136, USA., Díaz Mosquera GA; Integral Solutions SD SAS, Integral Solutions Research, Bogota 110121, Colombia., Bonanad S; Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain., Cortes JM; Integral Solutions SD SAS, Integral Solutions Research, Bogota 110121, Colombia., Cazalla M; Instituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; CIBERER, Centro de Investigación en Red de Enfermedades Raras, Instituto de Salud Carlos III, 28029 Madrid, Spain., Gallego N; Instituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; CIBERER, Centro de Investigación en Red de Enfermedades Raras, Instituto de Salud Carlos III, 28029 Madrid, Spain.; ITHACA, European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability, 75019 Paris, France., Querol-Giner F; Physiotherapy in Motion Multispeciality Research Group (PTinMOTION), Department of Physiotherapy, University of Valencia, 46010 Valencia, Spain., Tenorio J; Instituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; CIBERER, Centro de Investigación en Red de Enfermedades Raras, Instituto de Salud Carlos III, 28029 Madrid, Spain.; ITHACA, European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability, 75019 Paris, France.; BITGENETIC LAB, Qube Technology Park, Tres Cantos, 28460 Madrid, Spain., López Guerrero JA; Doctoral School, Catholic University of Valencia San Vicente Mártir (UCV), 46002 Valencia, Spain.; Department of Pathology, Medical School, Catholic University of Valencia, San Vicente Martir, 46010 Valencia, Spain.; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2024 Aug 21; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje